David Arkowitz - 10 Jan 2025 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Director
Signature
/s/ Marc Banjak, Attorney-in-fact
Issuer symbol
IBIO
Transactions as of
10 Jan 2025
Net transactions value
+$49,999
Form type
4
Filing time
13 Jan 2025, 16:32:54 UTC
Previous filing
25 Nov 2024
Next filing
25 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBIO Common Stock Purchase $49,999 +18,382 $2.72 18,382 10 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased by Reporting Person pursuant to a Securities Purchase Agreement with iBio, Inc., dated January 10, 2025.